Table 2. Selected characteristics of candidemia patients by year of surveillance, in Atlanta (ATL) and Baltimore (BTM) metropolitan areas.

Characteristic		Y1	Y2	Y3	Y4	Y5	Change
Total Cases
ATL		541	526	487	419	351	−35%
BTM		440	354	323	202	205	−53%
Crude Incidence Rate
ATL		14.1	13.5	13.2	11.4	9.5	−33%
BTM		30.9	24.8	22.7	14.2	14.4	−54%
Patient group (n)
ATL	HO	405	374	335	270	226	−44%
HACO		124	135	136	128	111	−10%
CA		12	17	16	21	14	17%
BTM	HO	253	223	182	121	111	−56%
HACO		175	122	131	72	79	−55%
CA		12	9	10	9	15	25%
Central Venous Catheter within 2 days of candidemia (n)
ATL	All ages	473	454	421	349	294	−38%
<1 year of age		14	22	6	4	9	−36%
> = 65 years of age		159	138	158	118	93	−42%
BTM	All ages	384	312	262	155	151	−61%
<1 year of age		10	9	6	3	6	−40%
> = 65 years of age		136	114	77	58	49	−64%
Surgery among patients who did not have a CVC (n)
ATL	Ab surgery	11	6	6	9	6	−45%
Non ab surgery		7	4	6	6	7	0%
BTM	Ab surgery	6	11	10	6	6	0%
Non ab surgery		7	5	3	5	7	0%
Species-Specific Incidence Rates (IR)
ATL	CA	5.91	5.73	5.59	4.86	3.72	−37%
CG		4.28	3.62	3.35	2.72	2.86	−33%
CP		2.38	2.62	2.39	2.25	1.63	−31%
CT		0.71	0.80	1.22	0.90	0.73	4%
CK		0.27	0.26	0.19	0.19	0.25	−8%
Other		0.42	0.54	0.70	0.38	0.46	8%
BTM	CA	11.60	9.18	7.72	4.56	5.12	−56%
CG		9.34	8.14	8.20	5.68	4.97	−47%
CP		5.41	4.07	3.51	1.69	1.47	−73%
CT		3.53	3.03	3.15	1.33	1.97	−44%
CK		0.43	0.37	0.14	0.14	0.28	−35%
Other		0.93	0.99	1.20	0.47	0.69	−26%
% Resistant to Fluconazole
ATL		8%	9.38%	5.67%	7%	7.14%	−10%
BTM		6.57%	8.07%	4.73%	4.50%	4.93%	−25%
% Resistant to an Echinocandin
ATL		1.18%	1.44%	0.99%	0.83%	2.92%	147%
BTM		1.95%	0.58%	2.21%	2.50%	3.45%	77%
% Multidrug Resistant Candida
ATL		0.18%	0.38%	0%	0.48%	0.85%	372%
BTM		0.91%	0%	0.62%	0.50%	0.98%	8%

Note: HO, healthcare onset. HACO, healthcare-associated community-onset. CA, community-acquired. Ab surgery, abdominal surgery. Y, year.